ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,135Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 103

$667K Total Retail Price of All Prescriptions

Rank: 16 out of 103

593 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 593 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 593 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 11,997 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 616 573 1 1
SIMVASTATIN 510 492 2 2
OMEPRAZOLE 497 471 3 3
TRAMADOL HCL 495 442 4 17
HYDROCHLOROTHIAZIDE 468 446 5 16
LISINOPRIL 464 422 6 5
FUROSEMIDE 418 362 7 4
WARFARIN SODIUM 349 321 8 7
METOPROLOL SUCCINATE 296 291 9 8
METOPROLOL TARTRATE 282 271 10 9
AMLODIPINE BESYLATE 271 264 11 6
POTASSIUM CHLORIDE 261 238 12 10
METFORMIN HCL 260 215 13 13
CITALOPRAM HBR 247 230 14 15
GABAPENTIN 239 205 15 22
ATENOLOL 222 205 16 14
TAMSULOSIN HCL 193 180 17 23
LOSARTAN POTASSIUM 184 181 18 12
HYDROCODONE-ACETAMINOPHEN 176 173 S3 19 11
CRESTOR 163 147 20 27
DIGOXIN 147 132 21 25
ALLOPURINOL 145 140 22 26
ZOLPIDEM TARTRATE 145 140 22 29
ATORVASTATIN CALCIUM 141 141 24 18
PRAVASTATIN SODIUM 140 136 25 33
CARVEDILOL 135 125 26 20
DONEPEZIL HCL 131 131 27 28
MIRTAZAPINE 128 116 28 36
FLUTICASONE PROPIONATE 107 103 29 35
LOSARTAN-HYDROCHLOROTHIAZIDE 105 105 30 47
SERTRALINE HCL 99 94 31 21
DIOVAN 98 94 32 40
TRAZODONE HCL 94 75 33 52
POLYETHYLENE GLYCOL 3350 86 79 34 31
ALENDRONATE SODIUM 85 84 35 19
ADVAIR DISKUS 82 79 36 42
SYNTHROID 81 67 37 51
KLOR-CON M20 80 80 38 56
OXYBUTYNIN CHLORIDE ER 79 73 39 74
NAMENDA 77 77 40 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 76 41 48
ENALAPRIL MALEATE 70 60 42 63
CYMBALTA 68 31 43 60
AZITHROMYCIN 63 53 44 44
PREDNISONE 62 51 45 24
TRIAMCINOLONE ACETONIDE 61 58 46 107
NEXIUM 61 47 46 43
GLIMEPIRIDE 61 61 46 50
SPIRONOLACTONE 57 56 49 30
RISPERIDONE 57 57 49 88
TRIAMTERENE-HCTZ 56 56 51 38
LYRICA 56 32 51 109
CYCLOBENZAPRINE HCL 54 37 R 53 83
AMITRIPTYLINE HCL 52 39 R 54 54
GLIPIZIDE 50 50 55 65
CIPROFLOXACIN HCL 50 47 55 59
DILTIAZEM 24HR CD 50 38 55 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.